Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Prakash

Showing results (331-340 of 339) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 339 results.
The Journal of Biological Chemistry|August 1, 2000
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitorsD Seiffert, J D Bradley, C M Rominger, et al.
Molecular Metabolism|December 31, 2021
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loopYihui Chen, Michela Capello, Mayrim V Rios Perez, et al.
JAMA Surgery|July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Cancers|October 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case SeriesAshwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Annals of Surgery|April 7, 2023
Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical TrialAn T Ngo-Huang, Nathan H Parker, Lianchun Xiao, et al.
Cancer Cell|April 3, 2018
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic CancerYing-Nai Wang, Heng-Huan Lee, Chao-Kai Chou, et al.
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
Neurology|December 14, 2005
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD StudyS Karamohamed, J C Latourelle, B A Racette, et al.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
Pageof 34

Showing results (331-340 of 339) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 339 results.
The Journal of Biological Chemistry|August 1, 2000
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitorsD Seiffert, J D Bradley, C M Rominger, et al.
Molecular Metabolism|December 31, 2021
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loopYihui Chen, Michela Capello, Mayrim V Rios Perez, et al.
JAMA Surgery|July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Cancers|October 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case SeriesAshwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Annals of Surgery|April 7, 2023
Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical TrialAn T Ngo-Huang, Nathan H Parker, Lianchun Xiao, et al.
Cancer Cell|April 3, 2018
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic CancerYing-Nai Wang, Heng-Huan Lee, Chao-Kai Chou, et al.
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
Neurology|December 14, 2005
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD StudyS Karamohamed, J C Latourelle, B A Racette, et al.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
Pageof 34